NEUARTIGE BENZODIAZEPINDERIVATE

Patent europeic · EP3100745 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3100745
Numer da la dumonda
EP16176289
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
04-02-2010
Publitgà
07-12-2016
Concedì
18-04-2018
Stritgà
28-02-2019
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 487/04 (2006.01)
C07D 498/04 (2006.01)
C07D 519/00 (2006.01)
A61K 31/5517 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 150201 P 05.02.2009
Derivà da
EP10739103
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-09-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.09.2019

  2. 18-04-2018

    Concedì

    Published in Swissreg on 18.04.2018

Partidas

Possessur

ImmunoGen, Inc.

Immunogen, Inc.

830 Winter Street, Waltham, MA 02451, US

Inventur

LI, Wei

Acton, MA 01720, US

FISHKIN, Nathan Elliott

Weymouth, MA 02190, US

ZHAO, Robert Yongxin

Lexington, MA02420, US

MILLER, Michael Louis

Framingham, MA 01701, US

CHARI, Ravi V J

Newton, MA 02461, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.